Back to the feed
In brief
On 25.09.2024, a person holding the function "Executive member of the board of directors / senior management" at Kuros Biosciences AG disclosed a sale worth CHF 8’226’000 to SIX Exchange Regulation.
This is the largest management sale disclosed at Kuros Biosciences AG over the previous 12 months (13 sales in total).
insider24.ch
Never miss a market signal again
Create a free account
Need more? Discover the Pro plan
Pro alertsEmail and Telegram after publication
Unlimited company trackingUnlimited watchlist with the Pro plan
Monday recapYour stocks' essentials at the open
Disclosure detail
A executive member of the board of directors / senior management of Kuros Biosciences AG declared a "Sale" transaction on 25.09.2024.
SIX publishes the manager's function, never their name: no individual is named in management transactions.
Transaction date25.09.2024
Issuing companyKuros Biosciences AG
ISINCH0325814116
Transaction sideSale
Management functionExecutive member of the board of directors / senior management
Security typeRegistered shares
Quantity450’000
Unit priceCHF 18.28
AmountCHF 8’226’000
Related partyRelated natural person
ConditionsBlocksale, price of CHF 18.28, sold to long-term
institutional shareholders
ExchangeXSWX
Notification IDT1O9P00073
Other Kuros Biosciences AG insider transactions
- Purchase · Executive member of the board of directors / senior management19.10.2026CHF 282’505
- Sale · Executive member of the board of directors / senior management06.10.2026CHF 552’000
- Purchase · Executive member of the board of directors / senior management22.09.2026CHF 30’600
- Purchase · Executive member of the board of directors / senior management17.09.2026CHF 115’322
- Sale · Executive member of the board of directors / senior management26.05.2026CHF 139’385
These figures aggregate public disclosures. They are not investment advice.